Dr. Spurgeon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-6101
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2006 - 2009- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2002 - 2006
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2002
Certifications & Licensure
OR State Medical License 2005 - 2025- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) Start of enrollment: 2009 Sep 01
- Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia Start of enrollment: 2011 Oct 01
- Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia Start of enrollment: 2012 May 11
- Join now to see all
Publications & Presentations
PubMed
- 783 citationsFunctional genomic landscape of acute myeloid leukaemiaJeffrey W. Tyner, Cristina E. Tognon, Daniel Bottomly, Beth Wilmot, Stephen E. Kurtz
Nature. 2018-10-17 - 113 citationsIntegrative analysis of drug response and clinical outcome in acute myeloid leukemia.Daniel Bottomly, Nicola Long, Anna Reister Schultz, Stephen E Kurtz, Cristina E Tognon
Cancer Cell. 2022-08-08 - 1216 citationsTargeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell LymphomaMichael L. Wang, Simon Rule, Peter Martin, Andre Goy, Rebecca Auer
The New England Journal of Medicine. 2013-08-07
Abstracts/Posters
- SYK Inhibitor Entospletinib in Combination with Obinutuzumab Demonstrates Efficacy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Stephen E Spurgeon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- TAK-243, a Small Molecule Inhibitor of Ubiquitin-Activating Enzyme (UAE), Induces ER Stress and Apoptosis in CLL Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- TAK-243, a Small Molecule Inhibitor of Ubiquitin-Activating Enzyme (UAE), Induces ER Stress and Apoptosis in CLL Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
